As of 2026-03-28, the Relative Valuation of USANA Health Sciences Inc (USNA) is 15.88 USD. This relative valuation is based on P/E multiples. With the latest stock price at 17.28 USD, the upside of USANA Health Sciences Inc based on Relative Valuation is -8.1%.
The range of the Relative Valuation is 9.81 - 25.52 USD.
| Range | Selected | |
| Trailing P/E multiples | 21.2x - 22.8x | 22.0x |
| Forward P/E multiples | 13.0x - 18.8x | 15.9x |
| Fair Price | 9.81 - 25.52 | 15.88 |
| Upside | -43.3% - 47.7% | -8.1% |
| Date | P/E |
| 2026-03-26 | 37.36 |
| 2026-03-25 | 37.17 |
| 2026-03-24 | 36.78 |
| 2026-03-23 | 37.58 |
| 2026-03-20 | 36.56 |
| 2026-03-19 | 37.06 |
| 2026-03-18 | 36.95 |
| 2026-03-17 | 38.18 |
| 2026-03-16 | 37.92 |
| 2026-03-13 | 37.49 |
| 2026-03-12 | 37.21 |
| 2026-03-11 | 38.07 |
| 2026-03-10 | 38.55 |
| 2026-03-09 | 38.16 |
| 2026-03-06 | 38.55 |
| 2026-03-05 | 39.35 |
| 2026-03-04 | 41.79 |
| 2026-03-03 | 42.05 |
| 2026-03-02 | 43.44 |
| 2026-02-27 | 46.53 |
| 2026-02-26 | 45.75 |
| 2026-02-25 | 45.97 |
| 2026-02-24 | 46.83 |
| 2026-02-23 | 47.18 |
| 2026-02-20 | 46.85 |
| 2026-02-19 | 44.43 |
| 2026-02-18 | 41.08 |
| 2026-02-17 | 44.67 |
| 2026-02-13 | 45.19 |
| 2026-02-12 | 45.32 |
| 2026-02-11 | 45.71 |
| 2026-02-10 | 46.33 |
| 2026-02-09 | 45.84 |
| 2026-02-06 | 46.14 |
| 2026-02-05 | 44.99 |
| 2026-02-04 | 45.19 |
| 2026-02-03 | 44.19 |
| 2026-02-02 | 46.83 |
| 2026-01-30 | 46.92 |
| 2026-01-29 | 46.87 |
| 2026-01-28 | 46.20 |
| 2026-01-27 | 47.87 |
| 2026-01-26 | 48.04 |
| 2026-01-23 | 48.71 |
| 2026-01-22 | 48.67 |
| 2026-01-21 | 48.09 |
| 2026-01-20 | 47.50 |
| 2026-01-16 | 47.42 |
| 2026-01-15 | 46.70 |
| 2026-01-14 | 44.28 |